Page last updated: 2024-10-30

metformin and Cross Infection

metformin has been researched along with Cross Infection in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Cross Infection: Any infection which a patient contracts in a health-care institution.

Research Excerpts

ExcerptRelevanceReference
"131 949 patients with type 2 diabetes who initiated pharmacotherapy with a GLD between 2005 and 2012."1.43Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study. ( Mor, A; Petersen, I; Sørensen, HT; Thomsen, RW, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mor, A1
Petersen, I1
Sørensen, HT1
Thomsen, RW1

Other Studies

1 other study available for metformin and Cross Infection

ArticleYear
Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study.
    BMJ open, 2016, 08-19, Volume: 6, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Community Health Services; Cross Infection; Denm

2016